Seven Mile Advisory’s GSK GSK Stock Holding History

Seven Mile Advisory’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$204K	Buy	3,860 +223	+6%	+$11.8K	0.14%	146
2026 Q1	$201K	Sell	3,637 -854	-19%	-$46.3K	0.14%	168
2025 Q4	$220K	Buy	+4,491	New	+$209K	0.04%	223
2025 Q2	–	Sell	-6,142	Closed	-$238K	–	185
2025 Q1	$238K	Buy	+6,142	New	+$225K	0.16%	143
2024 Q4	–	Sell	-6,346	Closed	-$259K	–	176
2024 Q3	$259K	Buy	6,346 +686	+12%	+$28.1K	0.17%	122
2024 Q2	$218K	Buy	5,660 +16	+0.3%	+$673	0.16%	130
2024 Q1	$242K	Sell	5,644 -563	-9%	-$23.2K	0.18%	121
2023 Q4	$230K	Buy	6,207 +30	+0.5%	+$1.08K	0.2%	116
2023 Q3	$224K	Buy	+6,177	New	+$219K	0.24%	99

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Seven Mile Advisory's GSK Position: Q2 2026 in Review

Seven Mile Advisory increased its GSK (GSK) stake by 6.1% in Q2 2026, buying an estimated $11.8K and bringing the position to 3,860 shares worth $204K. The position accounts for 0.14% of the portfolio, ranked #146.

Seven Mile Advisory first reported a position in GSK in Q3 2023 and has held it in 9 quarters since. The position peaked at $259K in Q3 2024. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

Seven Mile Advisory held 3,860 shares of GSK worth $204K as of Q2 2026.
Seven Mile Advisory bought 223 GSK shares in Q2 2026, an estimated $11.8K.
GSK made up 0.14% of Seven Mile Advisory's portfolio in Q2 2026, its #146 holding.
Seven Mile Advisory first reported a position in GSK in Q3 2023 and has held it in 9 quarters since.
Seven Mile Advisory's GSK position peaked at $259K in Q3 2024.
1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Seven Mile Advisory's 13F filing for Q2 2026, filed 13 Aug 2026.